Search

everythinglearnresearchcommunity

for

Search:↓

Sandalore®, a synthetic scent, reduced hair loss and improved hair growth in women with telogen effluvium.

Higher DHEA-S levels are linked to smaller ovarian volume in women with PCOS.

Male pattern baldness may be an early sign of noncancerous prostate enlargement.

The conclusion is that a more comprehensive and precise approach is needed for diagnosing PCOS to address its broader health risks.

Calcitriol and metformin together are more effective for treating PCOS and lowering MCP-1 than metformin alone.

Different treatments are effective for hair loss conditions, but results vary by individual factors.

A vitamin and mineral supplement significantly reduced hair shedding in Brazilian women with telogen effluvium.

Hair is culturally and economically valuable, and its weight is now used to measure the effectiveness of hair growth treatments.

Using hair loss drugs finasteride and dutasteride may cause sexual side effects.

Hair loss treatments show limited improvement, sunscreen thickness affects vitamin D production, and the effectiveness of IVIg for toxic epidermal necrolysis is uncertain.

Testosterone increases muscle mass regardless of DHT conversion blocking.

Men with early balding may have a higher risk of prostate issues, and surgery for prostate cancer has a slight survival benefit over radiation.

As women age, they experience changes in hair density and volume, face challenges in distinguishing normal hair loss from disease, and have limited access to treatments for hair issues.

Urinary PSA could be an early marker for enlarged prostate.

Biofeedback treatment for dysfunctional voiding in adults showed no symptom improvement.

Both finasteride and drospirenone effectively manage PCOS symptoms, but drospirenone is more effective in reducing ovarian volume and androgen levels.

Human prostate cells produce more WISP1/CCN4 when there's not enough oxygen.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

Finasteride improves urinary symptoms and quality of life in BPH patients, especially with larger prostate size.

Combination therapy with Finasteride is more effective than alpha-blocker alone for BPH symptoms in small prostate volume.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

The best results in surgical hair restoration come from careful techniques, optimal use of limited hair supply, correct hair direction, saving hair for key areas, understanding scarring effects, and adjusting hair graft density.

Spironolactone effectively reduces unwanted hair growth in women with hirsutism.

Using oral minoxidil and dutasteride together can quickly increase hair growth and volume with minimal side effects.

Stopping finasteride improves sperm quality but not semen volume in young men.

There is no link between hair loss and prostate enlargement.

Men with severe hair loss may have poorer sperm quality.

Early hair loss in men could be a sign of non-cancerous prostate enlargement, and treating hair loss early might help prevent prostate issues later.

Hair loss can be an early sign of prostate enlargement.

People with early-onset hair loss (AGA) have a higher risk of heart disease, metabolic syndrome, and prostate enlargement.